AMERICAN JOURNAL OF PERINATOLOGY, cilt.31, sa.6, ss.463-467, 2014 (SCI İndekslerine Giren Dergi)
Background Some controlled trials have shown significant differences in short-term clinical outcomes between poractant alfa and beractant in infants with respiratory distress syndrome (RDS). There is, however, no study showing the differences in long-term outcomes with these treatments.